New cancer therapy from Türkiye advances in clinical development
✨ AI Summary
🔊 جاري الاستماع
A Türkiye-originated oncology drug candidate, RS-0139, has successfully completed its Phase 1 clinical trial, positioning itself as a key milestone in the...
